0.4553  -0.005 (-1.02%)		04-26 16:00
Open: 0.4789 High: 0.48 Volume: 158,461		Pre. Close: 0.46 Low: 0.4521 Market Cap: 12(M)

Short term
Mid term
Targets	6-month :	0.83	1-year :	1.15
Resists	First :	0.71	Second :	0.99
Pivot price	0.56
Supports	First :	0.26	Second :	0.21
MAs	MA(5) :	0.61	MA(20) :	0.52
	MA(100) :	0.31	MA(250) :	0.3
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	16.8	D(3) :	35.4
RSI	RSI(14): 47.5
52-week	High :	0.99	Low :	0.13

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ GCTK ] has closed above bottom band by 33.2%. Bollinger Bands are 385.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.48 - 0.48	0.48 - 0.49
Low:	0.44 - 0.45	0.45 - 0.45
Close:	0.45 - 0.46	0.46 - 0.46

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Thu, 25 Apr 2024
GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying - GlucoTrack (NASDAQ:GCTK), Bespoke Extracts ( - Benzinga

Thu, 25 Apr 2024
Director and 10% Owner Drew Sycoff Acquires 182540 Shares of GlucoTrack Inc (GCTK) - GuruFocus.com

Fri, 19 Apr 2024
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK - WICZ

Thu, 18 Apr 2024
GCTK Stock Price and Chart — NASDAQ:GCTK — TradingView - TradingView

Thu, 13 Apr 2023
Why Is GlucoTrack (GCTK) Stock Down 36% Today? - InvestorPlace

Sat, 27 Apr 2024

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	27 (M)
Shares Float	16 (M)
Held by Insiders	34.7 (%)
Held by Institutions	8.5 (%)
Shares Short	98 (K)
Shares Short P.Month	24 (K)

EPS	-0.38
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.15
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-121 %
Return on Equity (ttm)	-320.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.27
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-4 (M)

PE Ratio	-1.2
PEG Ratio	0
Price to Book value	3.03
Price to Sales	0
Price to Cash Flow	-1.86

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.